Click here to read the digital edition of the supplement
This supplement is supported by an educational education grant from Celgene and Janssen Biotech, Inc.
Topics Include:
- Advances in diagnosis and prognosis
- Management of the newly diagnosed patient
- Treatment advances and current management strategies for relapsed/refractory patients
- Future treatment directions
About the Author
Thomas R. Chauncey, MD, PhD
Associate Professor of Medicine and Oncology
University of Washington
Associate Member
Fred Hutchinson Cancer Research Center
Director, Marrow Transplant Unit
VA Puget Sound Health Care System
Seattle, WA